FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

18,284 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 7400 - 7600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1775Ophthalmia neonatorum (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1778Genital herpes (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1779Genital herpes (Disorders) (ICD10CM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1781Herpes (Tests for Herpes simplex virus Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1785Elevated liver enzyme (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1786Elevated liver enzyme (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1788Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1789Granuloma Inguinale (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1791Ulcer [Genital, Perineal, or Perianal Area] (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1792Ulcer [Genital, Perineal, or Perianal Area] (ICD10CM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1797Bronchial Wash (Specimen Type) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1800Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1803Bacteria (Tests in Sputum Specimen by Culture and Identification Method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1819Louseborne relapsing fever (Tests for Borrelia species)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1820Louseborne relapsing fever (Tests for Borrelia species in Blood)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1823Borrelia species (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1824Spirochetes (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1829Polyarthritis [Unspecified Cause] (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1835Rheumatoid nodules (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1842Ventilator associated event (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1844Leishmaniasis (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1846Leishmaniasis (Tests for Leishmania species Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1847Leishmaniasis (Tests for Leishmania species Antibody)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1848Leishmania species (Tests by Microscopic Observation in Tissue)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.185Brucellosis (Disorders) (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1864Taeniasis (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1866Taeniasis (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.187Dengue Virus Infection (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1875Cysticercosis (Tests for Taenia solium Antibody)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1878Surgical Site Infection (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1880Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acidactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1881NU_Tests for Enterobacteriaceae species Nucleic Acidactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1882Carbapenemase production (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1892Toxoplasmosis (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1893Toxoplasmosis (Disorders) (ICD10CM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1895Toxoplasmosis (Organism or Substance in Lab Results)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1897Toxoplasmosis (Tests by Microscopic Observation)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1898Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1901Toxoplasmosis (Tests for Toxoplasma gondii Antibody)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1902Orthopox (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1908Organisms (Tests by Electron Microscopic Observation)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1919Fungi [Causing Meningitis] (Tests by Culture and Identification Method)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1923Coronary artery aneurysm (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1924Coronary artery dilatation (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1925Ectatic coronary artery (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1926Left ventricular ejection fraction [Decreased Level] (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1927Coronary artery aneurysm (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1928Shock (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1929Shock (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1930Troponin [Elevated Level] (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1931Oral mucosa Inflammation (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1932Oral mucosa Inflammation (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1933C reactive protein (Tests by Any Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1934Lymphocytes [Concentration] (Tests by Any Method)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1935Strongyloidiasis (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1936Strongyloidiasis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1937Strongyloidiasis (Tests for Strongyloides Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1938Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1939Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1940Organisms (Tests by Microscopic Observation in Stool)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1941Strongyloidiasis (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1942Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1943Jamestown Canyon Virus Diseases (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1944Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1945Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1946Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1947Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1948Keystone Virus Diseases (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1949La Crosse Virus Diseases (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1950Snowshoe hare Virus Diseases (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1951Trivittatus Virus Diseases (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1952La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1953Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1954La Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1955Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1956La Crosse Virus Diseases (Tests for La Crosse Virus Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1957Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1958Trivittatus Virus Diseases (Tests for Trivittatus Virus Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1959Keystone Virus Diseases (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1960La Crosse Virus Diseases (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1961Snowshoe hare Virus Diseases (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1962Trivittatus Virus Diseases (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1963Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1964Encephalomyelitis (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1965Encephalomyelitis (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1966Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1967Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1968Hepatitis D Virus Infection (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1969Hepatitis D Virus Infection (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1970NU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1971Hepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1972Hepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1973Hepatitis D Virus Infection (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1974Baylisascariasis (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1975Baylisascariasis (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1976Baylisascariasis (Tests for Baylisascaris species Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1978Larva Migrans (Neural, Ocular, or Visceral) (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1979Larva Migrans (Neural, Ocular, or Visceral) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1980California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1981California Serogroup Virus Disease [Unspecified] (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1982California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1983California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1984California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1985California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1986Pregnant (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1987Flank Pain (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1988Bone Pain (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1989Abscess (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1990Abscess (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1991Focal Brain Lesions (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1992Pathologic Fractures [Unspecified Cause] (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1993Pathologic Fractures [Unspecified Cause] (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1994Granulomas (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1995Granulomas (ICD10CM)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1996Skin Lesions (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1997Skin Lesions (ICD10CM)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1998Angiostrongyliasis (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1999Lymphocytic Choriomeningitis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2000Lymphocytic Choriomeningitis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2001Lymphocytic Choriomeningitis (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2002Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2003Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2004Lymphocytic Choriomeningitis (Tests for LCMV Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2005Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2006Angiostrongyliasis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2007Eosinophilic meningitis (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2009Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2010Eosinophils [Concentration] (Tests in CSF by Any Method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2011Eosinophils [Percentage] (Tests in CSF by Any Method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2012Mpox (Tests for mpox virus by Genomic Sequencing)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2013Mpox (Test Panels for mpox virus by Genomic Sequencing)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2017Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2018Interpretation of an Observation (High)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2019Interpretation of an Observation (Low)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.202Trichinellosis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2020Lymphadenopathy [Acute] (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2023Tick Paralysis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2024Bacillary angiomatosis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2025Animal Bite or Scratch [Cat] (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2026Animal Bite or Scratch [Cat] (Disorders) (ICD10CM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2027Bartonellosis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2028Bartonellosis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2029Bartonellosis (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2030Bartonella henselae infection (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2031Bartonella quintana infection (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2032Bartonella bacilliformis infection (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2033Bartonella henselae infection (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2034Bartonella quintana infection (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2036Bartonella henselae (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2037Bartonella quintana (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2038Bartonella bacilliformis (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2039Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.204Giardiasis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2040Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2041Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2042Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2043Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2044Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2045Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2046Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2047Bartonellosis (Tests for Bartonella spp. Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2048Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2049Bartonella spp. (Tests by Microscopic Observation)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2050Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2051Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2052Echinococcosis (Disorders) (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2053Echinococcosis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2054Cystic Echinococcosis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2055Cystic Echinococcosis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2056Alveolar Echinococcosis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2057Alveolar Echinococcosis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2058Echinococcosis (Tests for Echinococcus species Antibody)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2059Echinococcus species (Tests by Microscopic Observation)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2060Echinococcosis (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2061Genital Warts (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2062Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2063Genital Warts (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2064Diphyllobothriasis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2065Diphyllobothriasis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2066Diphyllobothriasis (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2067Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2068Angiostrongyliasis (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2069Pelvic Inflammatory Disease (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2070Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2071Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2072Pelvic Inflammatory Disease (Disorders) (ICD10CM)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2073Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (ICD10CM)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2074Pelvic Inflammatory Disease [Unspecified] (Disorders) (ICD10CM)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2075Lower Abdominal Tenderness (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2076Lower Abdominal Tenderness (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2077Tenderness with motion of the cervix (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2078Adnexal Tenderness (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2079Uterine Tenderness (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2080Leukocytosis (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2081Leukocytosis (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2082Purulent material in the peritoneal cavity (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2083Pelvic Abscess (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2084Pelvic Abscess (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2085Leukocytes [Concentration] (Tests in Blood by Any Method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2087Nongonococcal Urethritis (Disorders) (SNOMED)active2023-01hl7